Revenue missed analyst estimates by 5.7%. Earnings per share (EPS) exceeded analyst estimates by 87%. Looking ahead, revenue is forecast to grow 56% p.a. on average during the next 3 years, compared ...
Bruce, Professional Relations Associate, 3M Pharmaceuticals, personal communication, March 2007). Of interest to us were the four subjects (15%) with reactions to fragrance mix. The positive ...
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in ...